Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
Medistep Healthcare IPO
Price Band
₹
Issue Size
₹16.1 Cr
Lot Size
3,000 shares
Min Investment
₹258,000
2 LOTS MIN
GMP
+₹8.0 (18.6%)
Issue Price
₹43.0
Subject to Sauda
₹18200
Paid only if allotted
Medistep Healthcare IPO AI Summary
- Medistep Healthcare IPO is listed on NSE SME in the Personal Care sector.
- Subscription window: 08 Aug–12 Aug 2025, listing on 18 Aug 2025.
- Current GMP is +₹8.0 (18.6%) — unofficial and can change daily.
Medistep Healthcare Limited is a newly established pharmaceutical company with a diverse product range and a commitment to quality. With a positive revenue and profit trajectory, the company is looking to expand through its IPO, offering shares at ₹43.0 with a minimum investment of ₹258,000.
TopFund is not SEBI-registered — this is educational analysis, not personalized investment advice.
Medistep Healthcare IPO — Third-Party Research Views
Reviews below reflect analyst calls made before this IPO closed on 12 Aug 2025 — not a current signal.
Recommendations are sourced from third-party research firms and are not TopFund's own investment advice.
Important Dates
Subscription Status
Subscription data unavailable
Medistep Healthcare IPO Grey Market Premium (GMP) Today
GMP
+₹8.0
GMP %
+18.6%
Est. Listing
₹51.0
Updated: 25 Jul 2026 14:13
About the Company
Incorporated in June 2023, Medistep Healthcare Limited is a pharmaceutical company producing sanitary pads, energy powder, and various pharmaceutical, nutraceutical, intimate, and surgical products. They are committed to quality and seek to expand their product line as a public, non-government company. The product includes the followings:- Sanitary Pads: Medistep produces high-quality sanitary pads, addressing essential feminine hygiene needs. Energy Powder: The company manufactures energy supplements designed to revitalize and invigorate consumers. Pharmaceutical Products: Medistep engages in the trading of various pharmaceutical items, ensuring accessibility to essential medications. Nutraceutical Products: They offer products that blend nutrition and pharmaceuticals, promoting overall health and wellness. Intimate Care and Hygiene Products: The company provides personal hygiene and intimate care products. Surgical Products: Medistep supplies surgical items and supports medical professionals with necessary tools and equipment. As of December 30, 2024, Medistep reported annualized revenues of ₹45.00 crore and a Profit After Tax (PAT) of ₹4.08 crore. As of December 28, 2024, the company has nine employees on payroll. Labour needs depend on daily-paid labourers, and none are on contract. Competitive Strength: Experienced Promoters and Management Team. Maximize resources for quality supply and cost savings through economies of scale. Offers various products, including trading in pharmaceutical and healthcare items, manufacturing DRYSTEP sanitary pads, and VITASTEP Z energy powders.
Company Financials (₹ Cr)
As of 2025-03-31
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 22.99 | 14.96 | 14.66 |
| Total Income | 49.66 | 39.08 | 27.74 |
| Profit After Tax | 4.14 | 3.33 | 0.92 |
| EBITDA | 5.60 | 4.54 | 1.34 |
| NET Worth | 16.83 | 11.69 | 1.07 |
| Reserves and Surplus | 6.37 | 6.79 | |
| Total Borrowing | 0.64 | 0.33 | 0.53 |
Key Ratios
EPS
₹3.96
NAV
₹16.09
ROE
29.06%
ROCE
38.91%
RoNW
29.06%
P/B Value
2.67
P/E Ratio
10.86
Market Cap
₹61.10 Cr
PAT Margin
8.35%
Peer Comparison
| Company | NAV | RoNW | P/E (x) | EPS Basic | EPS Diluted |
|---|---|---|---|---|---|
| Achyut Healthcare Ltd | 1.33 | 1.77% | 209 | 0.02 | 0.02 |
| Fabino Enterprises Limited | 20.42 | 3.12% | 41.27 | 0.63 | 0.63 |
| Medistep Healthcare Limited This IPO | 16.28 | 24.62% | 10.72 | 4.01 | 4.01 |
Promoters
Girdhari Lal Prajapat, Dabhi Vipul Gobarbhai, Prajapati Hetalben Girdharilal and Jagdish Prajapati
Objects of the Issue
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 Funding of capital expenditure towards purchase of plant and machineries for expansion at the existing manufacturing facility 0.51 2 Working Capital Requirements 12.34 3 General Corporate Purposes 1.64 4 Issue Expenses 1.61 Total 16.10
IPO Evaluation
Generated 23 Sep 2026Revenue Trend
Revenue was ₹27.74 Cr in the year ending 31 Mar 2023, rising to ₹39.08 Cr by 31 Mar 2024, and further increasing to ₹49.66 Cr by 31 Mar 2025.
Profit Trend
Profit After Tax was ₹0.92 Cr in the year ending 31 Mar 2023, increasing to ₹3.33 Cr by 31 Mar 2024, and further rising to ₹4.14 Cr by 31 Mar 2025.
Valuation
Medistep Healthcare Limited has an implied P/E of 10.72 at the issue price, compared to peers trading at P/E ratios ranging from 41.27 to 209.
Grey Market Premium, Explained
The Grey Market Premium (GMP) indicates the price at which shares are expected to trade in the unofficial market before they are listed. A positive GMP suggests that the stock may list at a premium compared to its issue price.
Who This IPO Suits
Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against their overall investment strategy and risk tolerance. It's important to consider the company's growth potential and market conditions.
Who May Want to Wait
Investors with a low-risk appetite or those who prefer stable, established companies may want to avoid investing in this IPO, given the inherent risks associated with newly listed companies.
Listing Gains — The Risk
Listing-day gains can be unpredictable. While a positive GMP may indicate potential gains, market conditions, investor sentiment, and overall economic factors can influence the actual listing price. Investors should be prepared for volatility.
This evaluation is generated from Medistep Healthcare's own public IPO filing data for educational purposes and is not investment advice or a recommendation to apply, subscribe to, or avoid this issue — see Broker Recommendations below for named third-party research views (clearly attributed, not TopFund's own). TopFund is not a SEBI-registered investment adviser — see our Disclaimer.
Frequently Asked Questions
What is Medistep Healthcare IPO GMP today?
Medistep Healthcare IPO GMP today is +₹8.0 (18.6%). GMP is an unofficial grey-market indicator and can change daily.
When does Medistep Healthcare IPO open and close?
Medistep Healthcare IPO opens on 08 August 2025 and closes on 12 August 2025.
When does Medistep Healthcare IPO list on the stock exchange?
Medistep Healthcare IPO listed on 18 August 2025 at ₹51.0.
What is the lot size for Medistep Healthcare IPO?
The lot size for Medistep Healthcare IPO is 3000 shares, requiring a minimum investment of ₹258,000 (2 lots).
What is the lot size for this IPO?
The lot size for Medistep Healthcare's IPO is 3000 shares.
What is the minimum investment required?
The minimum investment required is ₹258,000.
What is the issue price of the shares?
The issue price of the shares is ₹43.0.
When does the IPO open and close?
The IPO opens on August 8, 2025, and closes on August 12, 2025.
What does GMP mean?
GMP stands for Grey Market Premium, which indicates the expected premium at which shares may trade in the grey market before listing.
Issue Details
Investor Allocation
Registrar
Lead Managers / Book Running
IPO Timeline
Open
08 Aug 2025
Close
12 Aug 2025
Allotment
13 Aug 2025
Listing
18 Aug 2025
Similar IPOs in Personal Care
Plan Your IPO Investment
Related Articles
Community Sentiment
What are other investors planning for Medistep Healthcare?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.